Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A1 pseudogene 37 (HNRNPA1P37) is a processed pseudogene found in the human genome, cataloged by HGNC (HGNC:48766). Pseudogenes are DNA sequences resembling functional genes but have acquired mutations that prevent them from encoding functional proteins. While some pseudogenes can regulate gene expression at the RNA level (acting as ceRNAs or influencing microRNA activity), there is no evidence that HNRNPA1P37 plays such a role. It should not be considered a canonical therapeutic target or molecular receptor, since it does not encode a functional protein and has not been implicated in disease mechanisms or targeted by drugs. If a molecular target is needed for drug development or biomarker study, information should be sought for the functional parental gene/protein "Heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1)", which is involved in RNA binding and processing, rather than this pseudogene.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 37 (HNRNPA1P37).